title: Successful management of life-threatening disseminated intravascular coagulopathy due to metastatic melanoma.
authors: Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
authors: A
authors: A
authors: Bhattacharyya
authors: A
authors: A
authors: Cooper
authors: A
authors: A
authors: Hong
authors: H
authors: H
authors: Iland
authors: C
authors: C
authors: McNeil
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008545:Melanoma / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D008875:Middle Aged; D009154:Mutation; D009367:Neoplasm Staging; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors / Q000235:genetics; D013449:Sulfonamides / Q000008:administration & dosage*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf